Lipoprotein-associated phospholipase A2 (Lp-PLA2) is produced by inflammatory cells and circulates primarily bound to low-density lipoprotein (LDL) and is to a lesser extent associated with high-density lipoprotein (HDL) in human plasma. LDL oxidation is known as an early key event in the pathogenesis of atherosclerosis. Elevated Lp-PLA2 levels have been found in atherosclerotic plaques and rupture lesions.
1B10-5 ~ 1D2-1
|Purity||>95%, determined by SDS-PAGE|
|Buffer Formulation||PBS, pH7.4.|
|Storage||Store it under sterile conditions at -20℃ to -80℃ upon receiving.
Recommend to aliquot the protein into smaller quantities for optimal storage.
|Product Name||Cat. No||Clone ID|
Note: Bioantibody can customized quantities per your need.
1.Li D , Wei W , Ran X , et al. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis[J]. Clinica Chimica Acta, 2017, 471:38.
2.Wilensky R L , Macphee C H . Lipoprotein-associated phospholipase A(2) and atherosclerosis.[J]. Current Opinion in Lipidology, 2009, 20(5):415-420.